missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX Ibrutinib (PCI-32765)
Click to view available options
:
5 mg
Description
Ibrutinib (PCI-32765, Imbruvica) is an FDA approved drug that targets B-cell malignancies and is approved for treatment of mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib is an orally-bioavailable compound that is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK). Also inhibits YES and other SRC family tyrosine kinases. Provided as 5mg of dry powder.
Specifications
Specifications
| Quantity | 5 mg |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction